Arthur Cox is continuing to closely monitor Brexit developments, and to advise our clients in Ireland, the UK and further afield on the potential legal implications for their businesses. We are also mindful of the implications of Brexit for Northern Ireland and free movement of goods and people across the border. Together with our colleagues in our Belfast office, we have an all-island perspective on these issues.
For the time being, the manner in which the UK will leave the EU, and the shape of the future trading relationship between the UK and the EU, remains uncertain, in particular following the rejection by the House of Commons of the draft Withdrawal Agreement on 15 January 2019. We will issue updates and relevant briefings as further developments occur.
In the meantime, if you have any questions on Brexit, please get in touch with your usual Arthur Cox contact or any member of our Brexit team.
Our previous Brexit briefings provide further background on Brexit-related developments:
- Data Flows Post-Brexit: Latest Developments
- Brexit: EBA sets out its supervisory expectations
- Brexit and the Irish Life Sciences Industry
- The Irish Health Products Regulatory Authority vows to protect the availability of medicines to Irish patients post-Brexit
- Brexit: Central Bank FAQ
- Brexit Guidance for the Pharmaceutical Industry
- Brexit: ESMA publishes sector-specific opinions on relocations
- Brexit: ESMA highlights importance of supervisory convergence
- Brexit Update May 2017
- Brexit: The Great Repeal Bill
- Article 50 triggered: Brexit negotiations can begin
- January 2017 Briefing on the Supreme Court decision on Article 50
- November 2016 Brexit Update
- November 2016 Briefing on the High Court ruling on Article 50